These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34579023)

  • 21. Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A.
    Choi YJ; Koo JB; Kim HY; Seo JW; Lee EJ; Kim WR; Cho JY; Hahm KB; Hong SP; Kim DH; Yoo JH
    Stem Cell Res Ther; 2019 Sep; 10(1):291. PubMed ID: 31547873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease.
    Lovisa S; Genovese G; Danese S
    J Crohns Colitis; 2019 Apr; 13(5):659-668. PubMed ID: 30520951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fibrogenesis and inflammatory bowel disease].
    Sans M; Masamunt MC
    Gastroenterol Hepatol; 2007 Jan; 30(1):36-41. PubMed ID: 17266880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary Composition and Effects in Inflammatory Bowel Disease.
    Castro F; de Souza HSP
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31234325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms and models for intestinal fibrosis in IBD.
    De Salvo C; Ray S; Pizarro TT
    Dig Dis; 2014; 32 Suppl 1():26-34. PubMed ID: 25531350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal organoids: a model of intestinal fibrosis for evaluating anti-fibrotic drugs.
    Rodansky ES; Johnson LA; Huang S; Spence JR; Higgins PD
    Exp Mol Pathol; 2015 Jun; 98(3):346-51. PubMed ID: 25828392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular and Molecular Mediators of Intestinal Fibrosis.
    Lawrance IC; Rogler G; Bamias G; Breynaert C; Florholmen J; Pellino G; Reif S; Speca S; Latella G
    J Crohns Colitis; 2017 Dec; 11(12):1491-1503. PubMed ID: 25306501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel Disease.
    Sáez-González E; Mateos B; López-Muñoz P; Iborra M; Moret I; Nos P; Beltrán B
    Nutrients; 2019 May; 11(5):. PubMed ID: 31083616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory bowel disease: the role of environmental factors.
    Danese S; Sans M; Fiocchi C
    Autoimmun Rev; 2004 Jul; 3(5):394-400. PubMed ID: 15288007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Environmental factors affecting inflammatory bowel disease: have we made progress?
    Lakatos PL
    Dig Dis; 2009; 27(3):215-25. PubMed ID: 19786744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolving intestinal fibrosis through regenerative medicine.
    Schwab R; Lim R; Goldberg R
    Curr Opin Pharmacol; 2019 Dec; 49():90-94. PubMed ID: 31689676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The fate of myofibroblasts during the development of fibrosis in Crohn's disease.
    Li C; Kuemmerle JF
    J Dig Dis; 2020 Jun; 21(6):326-331. PubMed ID: 32092217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
    Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
    BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models.
    Pucilowska JB; Williams KL; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2000 Oct; 279(4):G653-9. PubMed ID: 11005750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology.
    Rangan P; Choi I; Wei M; Navarrete G; Guen E; Brandhorst S; Enyati N; Pasia G; Maesincee D; Ocon V; Abdulridha M; Longo VD
    Cell Rep; 2019 Mar; 26(10):2704-2719.e6. PubMed ID: 30840892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Dietary Nutrients in Inflammatory Bowel Disease.
    Sugihara K; Morhardt TL; Kamada N
    Front Immunol; 2018; 9():3183. PubMed ID: 30697218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets.
    Lewis A; Nijhuis A; Mehta S; Kumagai T; Feakins R; Lindsay JO; Silver A
    Inflamm Bowel Dis; 2015 May; 21(5):1141-50. PubMed ID: 25636122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nr4A1 modulates inflammation-associated intestinal fibrosis and dampens fibrogenic signaling in myofibroblasts.
    Pulakazhi Venu VK; Alston L; Iftinca M; Tsai YC; Stephens M; Warriyar K V V; Rehal S; Hudson G; Szczepanski H; von der Weid PY; Altier C; Hirota SA
    Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(3):G280-G297. PubMed ID: 34288735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B lymphocyte intestinal homing in inflammatory bowel disease.
    Defendenti C; Sarzi-Puttini P; Grosso S; Croce A; Senesi O; Saibeni S; Bollani S; Almasio PL; Bruno S; Atzeni F
    BMC Immunol; 2011 Dec; 12():71. PubMed ID: 22208453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.